BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1841774)

  • 1. Calcium-antagonists in preventing restenosis following coronary angioplasty.
    Hoberg E; Kübler W
    Cardiologia; 1991 Dec; 36(12 Suppl 1):225-7. PubMed ID: 1841774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of restenosis after PTCA: role of calcium antagonists.
    Hoberg E; Kübler W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S15-9. PubMed ID: 1725911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists and prevention of post-angioplasty restenosis].
    Hoberg E
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():29-34. PubMed ID: 7503622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
    Kocurek A; Piwowarska W
    Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inefficacy of diltiazem in restenosis prevention after coronary angioplasty].
    Tanajura LF; Sousa AG; Feres F; Atallah T; Pinto IM; Centemero MP; Chaves AJ; Mattos LA; Martins HC; Abud RL
    Arq Bras Cardiol; 1994 Feb; 62(2):99-102. PubMed ID: 7944997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty.
    Schlant RC; King SB
    Circulation; 1989 Dec; 80(6 Suppl):IV88-92. PubMed ID: 2688988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
    Hoberg E; Dietz R; Frees U; Katus HA; Rauch B; Schömig A; Schuler G; Schwarz F; Tillmanns H; Niebauer J
    Br Heart J; 1994 Mar; 71(3):254-60. PubMed ID: 8142195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of calcium antagonists after PTCA.
    Hoberg E
    Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
    Dens J; Desmet W; Piessens J
    Am Heart J; 2003 Mar; 145(3):404-8. PubMed ID: 12660661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril for prevention of restenosis after coronary angioplasty.
    Kaul U; Chandra S; Bahl VK; Sharma S; Wasir HS
    Indian Heart J; 1993; 45(6):469-73. PubMed ID: 8070823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of ticlopidine administration at low doses on the incidence of restenosis following percutaneous transluminal coronary angioplasty].
    Iñiguez Romo A; Macaya Miquel C; Hernández Antolín R; Casado Larre J; Alfonso Manterola F; Goicolea Ruigómez J; Zarco Gutiérrez P
    Rev Esp Cardiol; 1991; 44(6):366-74. PubMed ID: 1924952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high dose verapamil on restenosis after peripheral angioplasty.
    Schweizer J; Kirch W; Koch R; Hellner G; Uhlmann K
    J Am Coll Cardiol; 1998 May; 31(6):1299-305. PubMed ID: 9581724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.